Integrated Analysis of Microrna and mRNA Expression Profiles Related to Cardiovascular Disease in Monocytes from Systemic Lupus Erythematosus and Primary Antiphospholipid Syndrome Patients

被引:0
|
作者
Perez-Sanchez, Carlos [1 ]
Aguirre Zamorano, Maria Angeles [1 ]
Ruiz-Limon, Patricia [2 ]
Barbarroja, Nuria [1 ]
Jimenez-Gomez, Yolanda [1 ]
Carmen Abalos-Aguilera, Maria [2 ]
Arias de la Rosa, Ivan [2 ]
Galindo, Maria [3 ]
Collantes-Estevez, Eduardo [1 ]
Jose Cuadrado, Maria [4 ]
Lopez-Pedrera, Chary [1 ]
机构
[1] Univ Cordoba, Reina Sofia Hosp, IMIBIC, Rheumatol Serv, Cordoba, Spain
[2] Univ Cordoba, Reina Sofia Hosp, IMIBIC, Rheumatol Serv, Cordoba, Spain
[3] Hosp 12 Octubre, Serv Reumatol, Madrid, Spain
[4] St Thomas Hosp, Lupus Res Unit, London, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
77
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Mechanisms of atherosclerosis and cardiovascular disease in antiphospholipid syndrome and systemic lupus erythematosus. New therapeutic approaches
    Lopez-Pedrera, Chary
    Angeles Aguirre-Zamorano, M.
    Perez-Sanchez, Carlos
    MEDICINA CLINICA, 2017, 149 (04): : 160 - 169
  • [42] Treatment of systemic lupus erythematosus and antiphospholipid syndrome: From experimental models to patients' bedside
    Krause, I
    Blank, M
    Shoenfeld, Y
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1996, 111 (04) : 355 - 361
  • [43] Valvular lesions in patients with systemic lupus erythematosus and antiphospholipid syndrome: An old disease but a persistent challenge
    Ferreira, Ester
    Bettencourt, Paulo M.
    Moura, Luis M.
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2012, 31 (04) : 295 - 299
  • [44] Subclinical vascular disease in patients with systemic lupus erythematosus: The additive deleterious effect of the antiphospholipid syndrome
    Jurcut, Ciprian
    Caraiola, Simona
    Nitescu, Doina
    Jurcut, Ruxandra
    Giusca, Sorin
    Baicus, Cristian
    Popescu, Bogdan A.
    Ginghina, Carmen
    Tanasescu, Coman
    JOINT BONE SPINE, 2012, 79 (06) : 628 - 629
  • [45] MicroRNA-126 and 146a as potential biomarkers in systemic lupus erythematosus patients with secondary antiphospholipid syndrome
    Nagy, Diana
    Shaheen, Noha H.
    Selim, Heba M.
    Sherif, Mai M.
    Saed, Salma M.
    Youssef, Hala R.
    Osman, Omneya
    Gaafar, Taghrid
    EGYPTIAN RHEUMATOLOGIST, 2020, 42 (03): : 201 - 206
  • [46] Increased Expression of Phospholipid Scramblase 1 in Monocytes from Patients with Systemic Lupus Erythematosus
    Suzuki, Eriko
    Amengual, Olga
    Atsumi, Tatsuya
    Oku, Kenji
    Hashimoto, Toko
    Kataoka, Hiroshi
    Horita, Tetsuya
    Yasuda, Shinsuke
    Ieko, Masahiro
    Fukushima, Kazuaki
    Koike, Takao
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (08) : 1639 - 1645
  • [47] Haem oxygenase 1 expression is altered in monocytes from patients with systemic lupus erythematosus
    Herrada, Andres A.
    Llanos, Carolina
    Mackern-Oberti, Juan P.
    Carreno, Leandro J.
    Henriquez, Carla
    Gomez, Roberto S.
    Gutierrez, Miguel A.
    Anegon, Ignacio
    Jacobelli, Sergio H.
    Kalergis, Alexis M.
    IMMUNOLOGY, 2012, 136 (04) : 414 - 424
  • [48] Clinical spectrum of males with primary antiphospholipid syndrome and systemic lupus erythematosus: a comparative study of 73 patients
    Medina, G
    Vera-Lastra, O
    Barile, L
    Salas, M
    Jara, LJ
    LUPUS, 2004, 13 (01) : 11 - 16
  • [49] The prevalence of antibodies to anionic phospholipids in patients with the primary antiphospholipid syndrome, systemic lupus erythematosus and their relatives and spouses
    Radway-Bright, EL
    Ravirajan, CT
    Isenberg, DA
    RHEUMATOLOGY, 2000, 39 (04) : 427 - 431
  • [50] ANTIPHOSPHOLIPID ANTIBODIES - A RISK FACTOR FOR OCCLUSIVE OCULAR VASCULAR-DISEASE IN SYSTEMIC LUPUS-ERYTHEMATOSUS AND THE PRIMARY ANTIPHOSPHOLIPID SYNDROME
    ASHERSON, RA
    MERRY, P
    ACHESON, JF
    HARRIS, EN
    HUGHES, GRV
    ANNALS OF THE RHEUMATIC DISEASES, 1989, 48 (05) : 358 - 361